Previous 10 | Next 10 |
home / stock / rhhvf / rhhvf news
2023-10-20 09:38:08 ET Summary Solid balance sheet, higher DPS expected, and firepower. Roche is a company to have. COVID-19 has positively impacted the company, and now Wall Street is discounting lower sales estimates. However, Roche is growing nicely. Despite a challenging e...
2023-10-19 19:15:23 ET Summary Positive interim analysis from its phase 2 CALLIPER study achieved, showing a statistically significant reduction in neurofilament light chain (NfL) in progressive multiple sclerosis patients when given vidofludimus calcium. Vidofludimus calcium perf...
2023-10-13 12:38:42 ET More on Roche Holding Roche: 2023 Should Mark The Bottom Roche: FX Drug But Positive Outlook Roche's Ocrevus' 10-year data shows MS drug cuts disability progression AbbVie blood cancer therapy fails in Phase 3 trial For further ...
2023-10-13 04:57:44 ET More on Roche Roche: Positive Readouts From Pipeline Roche: 2023 Should Mark The Bottom Roche: FX Drug But Positive Outlook Ionis licenses two candidates to Roche for Alzheimer's, Huntington's U.S. govt. to restart program to sh...
2023-09-19 14:45:33 ET Summary Regeneron Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Tarrytown that has played a key role in the fight against COVID-19. Regeneron's revenue for the second quarter of 2023 was $3.16 billion, an increase of 10.5% compared to th...
2023-09-18 15:00:29 ET Summary Roche's stock price has declined, underperforming its peers, due to the loss of patent protection for its blockbuster drugs, lower Covid-related revenue and several pipeline setbacks. The company has developed second-generation drugs and expanded int...
2023-09-16 08:26:36 ET Summary The sector as a whole is overvalued by about 15% relative to 11-year averages. Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. IXJ: a global alternative to ...
2023-08-29 13:45:03 ET Summary Yesterday, ImmunoGen, Inc. announced it has entered an exclusive licensing agreement with Takeda for the rights to develop and commercialize Mirvetuximab Soravtansine in the Japanese market. ImmunoGen's antibody drug conjugate - marketed and sold as ...
2023-08-23 14:46:51 ET Summary 14-week data from the phase 2 LUNA study, using Ixo-vec for the treatment of patients with wet age-related macular degeneration, expected in late Q3 of 2023. Preliminary safety and efficacy data from phase 2 LUNA study, using Ixo-vec for the treatmen...
2023-08-06 07:45:00 ET Summary Fiduciary Management, Inc. is an independent money management firm. FMI’s equity investing strategies apply a value discipline, with a focused approach firmly rooted in fundamental research. Global equity markets have continued to advance desp...
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Div Rts Company Name:
RHHVF Stock Symbol:
OTCMKTS Market:
Roche Holding Div Rts Website:
Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care Canada NewsWire At the global HIMSS 1 Conference, Roche showcases navify Algorithm Suite, a single platform offering cli...
Roche Announces Brad Moore as President and CEO of Roche Diagnostics North America PR Newswire INDIANAPOLIS , Dec. 5, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnost...